CELC Stock Analysis: Buy, Sell, or Hold?
CELC - Celcuity Inc. Common Stock
$131.06
0.35 (0.27%)
▲
5d:
+4.31%
30d:
+5.15%
90d:
+22.77%
BUY
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 14, 2026
3d
Smart Money Accumulation
CELC is down 3.3% this week, but smart money is accumulating calls. Top strike: $100 2026-06-18 with 415 OI. Call ratio: 78% View Scanner →
Strength: 4.4/10
Get Alerted When CELC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CELC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CELC shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CELC is currently trading at $131.06, which is considered extended relative to its 30-day fair value range of $113.67 to $130.67.
Technical Outlook: Technically, CELC is in a uptrend. Immediate support is located at $116.50, while resistance sits at $151.02.
Market Sentiment: CELC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $157.50 (+20.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CELC is in a uptrend. Immediate support is located at $116.50, while resistance sits at $151.02.
Market Sentiment: CELC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $157.50 (+20.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$113.67 -
$130.67
Company Quality Score
71/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.2% below Wall St target ($157.50)
Trading Range Analysis
30-Day Trading Range
$113.67 -
$130.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$116.50
Resistance Level
$151.02
Current Trend
Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-96.37
Wall Street Target
$157.50
(+20.2%)
Share & Embed Analysis
Last updated: May 10, 2026 3:08 PM ET
Data refreshes hourly during market hours. Next update: 4:08 PM
Data refreshes hourly during market hours. Next update: 4:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard E Buller
SELL
3000 shares
2026-03-31
David Dalvey
SELL
20000 shares
2026-01-27
Richard E Buller
SELL
3000 shares
2025-12-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 55 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$73 | 57 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 60 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 54 HOLD |
Advanced CELC Option Strategies
Professional options setups generated by AI based on today's CELC price and gamma walls.
